Company Overview Our People Senior Management J. Donald deBethizy, Ph.D. Merouane Bencherif, M.D., Ph.D. Jeffrey P. Brennan William S. Caldwell, Ph.D. Geoffrey C. Dunbar, M.D. Alan A. Musso, C.P.A., C.M.A. Peter A. Zorn, Esq. Mauri K. Hodges, C.P.A., C.C.P. Karen A. Hicks Board of Directors Our History Company Awards Product Pipeline AZD3480 (TC-1734) - Cognitive Impairment TC-5619 - Cognitive Dysfunction in Schizophrenia TC-5214 - Major Depressive Disorder TC-2216 - Depression/Anxiety Disorders TC-6499 - Neuropathic Pain Inversine® - Hypertension Science & Technology Targacept's Solution Neuronal Nicotinic Receptors (NNRs) NNRs: How They Work NNRs: Therapeutic Effects NNR Research Capabilities Patents Scientific Articles Research Grants Drug Discovery Pentad™        Business Development Licensing Opportunities Investor Relations Company Profile Stock Information SEC Filings Analyst Coverage Press Releases Annual Reports Investor Calendar Clinical and Scientific Calendar Board of Directors Senior Management Corporate Governance Investor Contact Information Request Form Investor FAQ Email Alerts Policy on Rumors Newsroom Press Releases Online Press Kit Event Calendar Careers Current Opportunities Our People Our Values Our Benefits Our Community Winston-Salem Business & Industry Winston-Salem Amenities Targacept in the Community Activities ©2008 Targacept, Inc. Terms of Use Home Directions Contact Site Map  Go